Follow The Filings

DAWN Day One Biopharmaceuticals

Filed as DAY ONE BIOPHARMACEUTICALS I (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 2 exits

In 2026 Q2 Nathan Fischel and George Soros sold out of Day One Biopharmaceuticals.

Who owns DAWN

Sorted by value, long equity only, as of 2026 Q2.

History
George Soros, Soros Fund Management exited 2026 Q2 Last 2026 Q1 0.36% Exit −0.36% 1,539,100 $33M History
Nathan Fischel, Dafna Capital Management exited 2026 Q2 Last 2026 Q1 4.8% Exit −4.77% 978,463 $21M History

0 current, 2 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.